PANS and PANDAS are conditions in which a child’s immune system, after fighting off an infection, mistakenly attacks the brain and triggers sudden, severe psychiatric symptoms. The hallmark is speed: a child who seemed fine days ago develops intense obsessive-compulsive behaviors, extreme anxiety, or dramatically restricted eating, often seemingly overnight. PANS stands for Pediatric Acute-onset Neuropsychiatric Syndrome, and PANDAS stands for Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections. PANDAS is actually a subtype of PANS, specifically triggered by strep bacteria.
How PANS and PANDAS Differ
The distinction between the two comes down to the trigger. PANDAS is tied specifically to streptococcal infections like strep throat or scarlet fever. PANS is the broader category and can be triggered by a variety of infections, including the flu, chicken pox, mycoplasma (a common cause of “walking pneumonia”), and Lyme disease. PANS can also be triggered by immune system problems or environmental factors that aren’t fully understood yet.
In practice, a child with PANDAS will typically have evidence of a recent strep infection, while a child diagnosed with the broader PANS label may have no identifiable strep connection at all. The symptoms, severity, and treatment approaches are largely the same for both.
What Causes the Symptoms
The underlying mechanism is a case of mistaken identity in the immune system. When the body fights a strep infection (or another trigger), it produces antibodies designed to attack the bacteria. In some children, those antibodies also happen to match proteins found on brain cells, a process called molecular mimicry. The antibodies cross into the brain when the blood-brain barrier is weakened by infection, and they bind to receptors involved in dopamine signaling.
This sets off a chain reaction. Immune cells activate in the brain, dopamine production ramps up abnormally, and key proteins that maintain healthy nerve connections are lost. The areas most affected are deep brain structures involved in movement, habit formation, and emotional regulation, along with parts of the brain that relay sensory and motor signals. That explains why the symptoms are so varied, spanning everything from compulsive rituals to involuntary movements to sudden emotional volatility.
Symptoms and How They Appear
The defining feature is the dramatic, sudden onset. Parents often describe a child who changed “overnight” or “within 48 hours.” The core symptoms required for a diagnosis are sudden-onset OCD or severely restricted food intake, plus at least two of the following:
- Anxiety, often severe separation anxiety that wasn’t there before
- Mood changes or depression
- Irritability, aggression, or severe oppositional behavior
- Loss of previously acquired skills, such as a child who could write neatly suddenly producing illegible handwriting, or a child losing age-appropriate language
- A sudden drop in school performance
- Unusual movements or sensory issues, including tics or heightened sensitivity to textures and sounds
- Sleep problems, frequent urination, or bedwetting in a child who was previously dry at night
These symptoms can’t be better explained by another known medical condition. What makes PANS and PANDAS distinct from typical childhood OCD or anxiety is that abrupt onset. A child who gradually develops mild compulsions over months is following a different pattern. In PANS and PANDAS, the change is sudden and often severe enough that parents say their child seems like a completely different person.
How It’s Diagnosed
There is no single blood test that confirms PANS or PANDAS. Diagnosis is clinical, meaning a provider pieces it together from the symptom pattern, the timeline, and evidence of a recent infection (particularly strep, in the case of PANDAS). Strep can be confirmed through a throat culture or blood tests measuring antibodies to strep bacteria.
One commercially available blood panel, known as the Cunningham Panel, measures antibodies against brain proteins and immune cell activation. However, independent research has raised serious concerns about its reliability. In a Swedish study evaluating the panel, 86% of healthy control subjects tested “positive,” compared to 92% of patients being assessed for PANS and PANDAS. Nearly half of healthy controls showed elevated immune activation on the panel’s key marker. Because the test flags the vast majority of healthy people as positive, it cannot reliably distinguish between children who have these conditions and those who don’t.
Treatment Approaches
Treatment for PANS and PANDAS generally works on three fronts: addressing the underlying infection, calming the immune response, and managing the psychiatric symptoms while the brain recovers.
If strep or another active infection is identified, antibiotics are used to clear it. For PANDAS specifically, some providers also prescribe ongoing low-dose antibiotics to prevent future strep infections from triggering new flares, though this remains a topic of debate among clinicians.
When the immune system is the primary driver, treatments aim to reduce the misdirected immune attack on the brain. Options range from anti-inflammatory medications to more intensive immune therapies. In moderate to severe cases, intravenous immunoglobulin (IVIG) infusions, which flood the body with healthy antibodies to help reset the immune response, are sometimes used.
On the psychiatric side, the same therapies that help with OCD and anxiety in other contexts can help here too: cognitive behavioral therapy and, in some cases, medications to manage symptoms while the underlying immune issue is being treated. The important distinction is that in PANS and PANDAS, psychiatric symptoms alone won’t fully resolve until the immune trigger is addressed.
Long-Term Outlook and Flares
The course of PANS and PANDAS varies widely from child to child. Some children have a single episode and fully recover. Others follow a relapsing-remitting pattern, improving significantly between flares but experiencing periodic worsening, often tied to new infections. A smaller group develops a more chronic course with persistent symptoms.
A follow-up study of 34 children from a Swedish PANS cohort (tracked for a median of 3.3 years) found that the majority improved significantly over time. However, only 2 of the 34 were classified as fully remitted. Twenty followed a relapsing-remitting course, and 12 had a chronic or progressive pattern. Children in the chronic group remained considerably more impaired at follow-up.
A separate long-term study of 33 children with PANDAS found a more encouraging picture overall. While 72% experienced at least one flare during the follow-up period (ranging from six months to nearly five years), only 12% still had clinically significant OCD symptoms at the end, and just 9% followed a truly chronic course. About a third received a new psychiatric diagnosis during follow-up, most commonly ADHD.
The pattern that emerges across studies is that most children do get substantially better, but flares are common and can be alarming when they happen. Families often learn to watch for signs of new infections as early warning signals. Each flare tends to follow the same rapid onset as the original episode, with symptoms intensifying over hours to days and then gradually improving as the immune response settles.